{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:43:05Z","timestamp":1771569785383,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s42000-023-00430-0","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:53:29Z","timestamp":1674111209000},"page":"343-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Long-term efficacy of empagliflozin as an add-on treatment for chronic SIAD: a case report and literature review"],"prefix":"10.1007","volume":"22","author":[{"given":"Fabio","family":"Bioletto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Varaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunzia","family":"Prencipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Benso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-2624","authenticated-orcid":false,"given":"Alessandro Maria","family":"Berton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"430_CR1","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1056\/NEJMcp066837","volume":"356","author":"DH Ellison","year":"2007","unstructured":"Ellison DH, Berl T (2007) The syndrome of inappropriate antidiuresis. N Engl J Med 356:2064\u20132072. https:\/\/doi.org\/10.1056\/NEJMcp066837","journal-title":"N Engl J Med"},{"key":"430_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","volume":"126","author":"JG Verbalis","year":"2013","unstructured":"Verbalis JG, Goldsmith SR, Greenberg A et al (2013) Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 126:S1-42. https:\/\/doi.org\/10.1016\/j.amjmed.2013.07.006","journal-title":"Am J Med"},{"key":"430_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-13-1020","volume":"170","author":"G Spasovski","year":"2014","unstructured":"Spasovski G, Vanholder R, Allolio B et al (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 170:G1-47. https:\/\/doi.org\/10.1530\/EJE-13-1020","journal-title":"Eur J Endocrinol"},{"key":"430_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/joim.12532","volume":"280","author":"B Winzeler","year":"2016","unstructured":"Winzeler B, Lengsfeld S, Nigro N et al (2016) Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis. J Intern Med 280:609\u2013617. https:\/\/doi.org\/10.1111\/joim.12532","journal-title":"J Intern Med"},{"key":"430_CR5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/cen.13930","volume":"90","author":"J Lockett","year":"2019","unstructured":"Lockett J, Berkman KE, Dimeski G et al (2019) Urea treatment in fluid restriction-refractory hyponatraemia. Clin Endocrinol (Oxf) 90:630\u2013636. https:\/\/doi.org\/10.1111\/cen.13930","journal-title":"Clin Endocrinol (Oxf)"},{"key":"430_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/cen.13315","volume":"86","author":"S Bhandari","year":"2017","unstructured":"Bhandari S, Peri A, Cranston I et al (2017) A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans. Clin Endocrinol (Oxf) 86:761\u2013771. https:\/\/doi.org\/10.1111\/cen.13315","journal-title":"Clin Endocrinol (Oxf)"},{"key":"430_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I et al (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet 393:31\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(18)32590-X","journal-title":"Lancet"},{"key":"430_CR8","doi-asserted-by":"publisher","first-page":"7815690","DOI":"10.1155\/2017\/7815690","volume":"2017","author":"J Refardt","year":"2017","unstructured":"Refardt J, Winzeler B, Meienberg F et al (2017) Empagliflozin increases short-term urinary volume output in artificially induced syndrome of inappropriate antidiuresis. Int J Endocrinol 2017:7815690. https:\/\/doi.org\/10.1155\/2017\/7815690","journal-title":"Int J Endocrinol"},{"key":"430_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/ASN.2019090944","volume":"31","author":"J Refardt","year":"2020","unstructured":"Refardt J, Imber C, Sailer CO et al (2020) A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis. J Am Soc Nephrol 31:615\u2013624. https:\/\/doi.org\/10.1681\/ASN.2019090944","journal-title":"J Am Soc Nephrol"},{"key":"430_CR10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022050623","author":"J Refardt","year":"2022","unstructured":"Refardt J, Imber C, Nobbenhuis R et al (2022) Treatment effect of the SGLT2 inhibitor empagliflozin on chronic syndrome of inappropriate antidiuresis: results of a randomized, double-blind, placebo-controlled, crossover trial. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2022050623","journal-title":"J Am Soc Nephrol"},{"key":"430_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1159\/000509082","volume":"51","author":"P Sarafidis","year":"2020","unstructured":"Sarafidis P, Loutradis C, Ferro CJ, Ortiz A (2020) SGLT-2 inhibitors to treat hyponatremia associated with SIADH: a novel indication? Am J Nephrol 51:553\u2013555","journal-title":"Am J Nephrol"},{"key":"430_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/1354750X.2021.1970808","volume":"26","author":"R Nobbenhuis","year":"2021","unstructured":"Nobbenhuis R, Refardt J, Vogt D et al (2021) Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers? Biomarkers 26:647\u2013655. https:\/\/doi.org\/10.1080\/1354750X.2021.1970808","journal-title":"Biomarkers"},{"key":"430_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-21-0604","volume":"186","author":"L Potasso","year":"2021","unstructured":"Potasso L, Refardt J, Meier C, Christ-Crain M (2021) Effect of hyponatremia normalization on osteoblast function in patients with SIAD. Eur J Endocrinol 186:1\u20138. https:\/\/doi.org\/10.1530\/EJE-21-0604","journal-title":"Eur J Endocrinol"},{"key":"430_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/S40800-017-0058-8","volume":"4","author":"G Gelbenegger","year":"2017","unstructured":"Gelbenegger G, Buchtele N, Schoergenhofer C et al (2017) Severe hypernatraemic dehydration and unconsciousness in a care-dependent inpatient treated with empagliflozin. Drug Saf - Case Rep 4:17. https:\/\/doi.org\/10.1007\/S40800-017-0058-8","journal-title":"Drug Saf - Case Rep"},{"key":"430_CR15","doi-asserted-by":"publisher","first-page":"e20228","DOI":"10.1097\/MD.0000000000020228","volume":"99","author":"IH Lee","year":"2020","unstructured":"Lee IH, Ahn DJ (2020) Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: a case report. Medicine (Baltimore) 99:e20228. https:\/\/doi.org\/10.1097\/MD.0000000000020228","journal-title":"Medicine (Baltimore)"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-023-00430-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00430-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T01:12:28Z","timestamp":1684977148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-023-00430-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1007\/s42000-023-00430-0","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.M.B. received fees from Thermo Fisher Diagnostics for previous editorial collaborations and oral presentations. The remaining authors report no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}